Search research articles
Contact Us
Filters
Showing results (301-310 of 343) with videos related to
Page
of 35
Sort By:
Gan
|
October 1, 1983
Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienols
M Kuwano, K Ikezaki, K Mamizuka, et al.
Journal of the National Cancer Institute
|
October 1, 1984
Potentiation of anticancer agents by new synthetic isoprenoids. II. Inhibition of the growth of transplantable murine tumors
T Yamaguchi, K Ikezaki, T Kishiye, et al.
Biochemical and Biophysical Research Communications
|
February 14, 1990
Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene
M Miyazaki, K Kohno, Y Saburi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas
A Nishie, K Masuda, M Otsubo, et al.
Cancer
|
June 5, 1999
Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
T Kamura, H Yahata, S Amada, et al.
Cancer Research
|
September 15, 1996
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
K Taniguchi, M Wada, K Kohno, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1997
Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells
Y Kikuchi, J Hirata, K Yamamoto, et al.
Bioorganic & Medicinal Chemistry
|
January 9, 1999
Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance
H Tanabe, S Tasaka, H Ohmori, et al.
International Journal of Cancer
|
May 16, 1998
Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
S Nakata, K Ito, M Fujimori, et al.
Oncology Research
|
July 17, 1998
Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer
K Ito, M Fujimori, S Nakata, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 343) with videos related to
Sort By:
Page
of 35
Gan
|
October 1, 1983
Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienols
M Kuwano, K Ikezaki, K Mamizuka, et al.
Journal of the National Cancer Institute
|
October 1, 1984
Potentiation of anticancer agents by new synthetic isoprenoids. II. Inhibition of the growth of transplantable murine tumors
T Yamaguchi, K Ikezaki, T Kishiye, et al.
Biochemical and Biophysical Research Communications
|
February 14, 1990
Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene
M Miyazaki, K Kohno, Y Saburi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas
A Nishie, K Masuda, M Otsubo, et al.
Cancer
|
June 5, 1999
Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
T Kamura, H Yahata, S Amada, et al.
Cancer Research
|
September 15, 1996
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
K Taniguchi, M Wada, K Kohno, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1997
Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells
Y Kikuchi, J Hirata, K Yamamoto, et al.
Bioorganic & Medicinal Chemistry
|
January 9, 1999
Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance
H Tanabe, S Tasaka, H Ohmori, et al.
International Journal of Cancer
|
May 16, 1998
Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
S Nakata, K Ito, M Fujimori, et al.
Oncology Research
|
July 17, 1998
Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer
K Ito, M Fujimori, S Nakata, et al.
Page
of 35